These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6347079

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [A phase II study with high-dose cytarabine (NS-075) in adult patients with relapsed and refractory acute leukemia].
    Miyawaki S, Mizoguchi H, Tomonaga M, Kanamaru A, Tsukagoshi S, Nakamura T, Ohashi Y, Yoshida S, Ohno R.
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2229-42. PubMed ID: 9881080
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of acute myelogenous leukemia with concurrent administration of N4-behenoyl-ara-C, aclacinomycin A, 6-mercaptopurine and prednisolone].
    Ino T, Saito M, Matsui T, Shimizu S, Shigemura H, Nakamura K, Ono Y, Okamoto M, Takada T, Imura H.
    Rinsho Ketsueki; 1985 Feb; 26(2):139-46. PubMed ID: 3860668
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Aclarubicin-related pancreatitis in a child with AML].
    Adachi S, Akiyama Y, Takimoto T, Tanizawa A, Kiriyama Y, Kubota Y, Mikawa H.
    Rinsho Ketsueki; 1988 Mar; 29(3):385-8. PubMed ID: 3165144
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy. The Japan Adult Leukemia Study Group.
    Miyawaki S, Kobayashi T, Tanimoto M, Kuriyama K, Murakami H, Yoshida M, Minami S, Minato K, Tsubaki K, Omoto E, Oh H, Jinnai I, Sakamaki H, Hiraoka A, Kanamaru A, Takahashi I, Saito K, Naoe T, Yamada O, Asou N, Kageyama S, Emi N, Ueda T, Tomonaga M, Ohno R.
    Int J Hematol; 1999 Jul; 70(1):56-7. PubMed ID: 10446497
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phase I-II study of aclarubicin for treatment of acute myeloid leukemia.
    Machover D, Gastiaburu J, Delgado M, Goldschmidt E, Hulhoven R, Misset JL, de Vassal F, Tapiero H, Ribaud P, Schwarzenberg L.
    Cancer Treat Rep; 1984 Jun; 68(6):881-6. PubMed ID: 6587933
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Acyclovir bioavailability in patients with acute myelogenous leukemia treated with daunorubicin and cytarabine.
    Sitar DS, Aoki FY, Bow EJ.
    J Clin Pharmacol; 2008 Aug; 48(8):995-8. PubMed ID: 18495946
    [No Abstract] [Full Text] [Related]

  • 14. Acute myeloblastic leukemia in adults.
    Kasthuri AS, Jaiprakash MP, Anand KP, Kumar R.
    J Assoc Physicians India; 1995 Feb; 43(2):108-10. PubMed ID: 9282674
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effects of small-dose cytarabine on the course of atheromatosis in over 60 years of age patients with acute myeloblastic leukemia (description of 2 cases)].
    Sokolov AN, Isaev VG, Savchenko VG.
    Ter Arkh; 2002 Feb; 74(12):66-7. PubMed ID: 12577846
    [No Abstract] [Full Text] [Related]

  • 17. Combination therapy with aclacinomycin in acute leukemia.
    Krc I, Myslivecek M, Mlcochová E.
    Acta Univ Palacki Olomuc Fac Med; 1986 Feb; 113():141-7. PubMed ID: 2941978
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.